articleArchives of General PsychiatryAug 1, 2003Closed access

Altered Gene Expression of Brain-Derived Neurotrophic Factor and Receptor Tyrosine Kinase B in Postmortem Brain of Suicide Subjects

University of Illinois Chicago · University of Maryland, Baltimore

PubMed
Indexed incrossrefpubmed

Abstract

Background

Suicide is a major public health concern. Although authors of many studies have examined the neurobiological aspects of suicide, the molecular mechanisms associated with suicidal behavior remain unclear. Brain-derived neurotrophic factor (BDNF), one of the most important neurotrophins, after binding with and activating receptor tyrosine kinase B (trk B), is directly involved in many physiological functions in the brain, including cell survival and synaptic plasticity. The present study was performed to examine whether the expression of BDNF and/or trk B isoforms was altered in postmortem brain in subjects who commit suicide (hereafter referred to as suicide subjects) and whether these alterations were associated with specific psychopathologic conditions.

Methods

These studies were performed in prefrontal cortex in Brodmann area 9 and hippocampus obtained in 27 suicide subjects and 21 nonpsychiatric control subjects. Levels of messenger RNA and protein levels of BDNF and trk B were determined with competitive reverse transcriptase-polymerase chain reaction and Western blot technique, respectively. The level of neuron-specific enolase messenger RNA as a neuronal marker was also determined in these brain areas.

Citation impact

870
total citations
FWCI
6.73
Percentile
100%
References
65
Citations per year

Authors

6

Topics & keywords

Keywords
  • Trk receptor
  • Neurotrophic factors
  • Tropomyosin receptor kinase B
  • Neurotrophin
  • Brain-derived neurotrophic factor
  • Hippocampus
  • Prefrontal cortex
  • Internal medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.